Pharma Mar, S.A. (BME:PHM)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	19.34	17.82	63.24	60.02	149.81	113.35
Short-Term Investments	149.54	149.41	91.29	102.54	32.61	88.53
Cash & Short-Term Investments	168.88	167.22	154.53	162.56	182.42	201.88
Cash Growth	31.85%	8.22%	-4.94%	-10.89%	-9.64%	3.26%
Accounts Receivable	47.7	39.05	34.27	27.2	29.32	50.91
Other Receivables	0.23	0.36	0.41	0.35	-	-
Receivables	47.93	39.41	34.68	27.55	29.32	50.91
Inventory	49.53	50.64	50.89	39.29	27.75	10.54
Prepaid Expenses	2.13	1.5	1.74	2.92	5.98	3.91
Other Current Assets	12.49	24.65	8.41	20.28	29.71	28
Total Current Assets	280.95	283.42	250.25	252.6	275.18	295.23
Property, Plant & Equipment	60.05	60.12	57.75	34.54	33.23	26.9
Long-Term Investments	0.61	0.58	2.46	6.06	49.4	10.72
Other Intangible Assets	4.01	1.36	1	1.23	1.19	1.13
Long-Term Deferred Tax Assets	47.14	46.55	36.01	31.47	30.53	27.75
Long-Term Deferred Charges	-	2.19	-	0.7	1.4	2.11
Other Long-Term Assets	0.85	0.87	2.18	13.91	2.33	4.55
Total Assets	393.6	395.08	349.64	340.52	393.26	368.39

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	38.93	40.91	38.81	29.17	27.49	26.93
Accrued Expenses	12.1	14.31	13.57	12.39	10.44	9.5
Short-Term Debt	4.06	4.79	4.72	6.46	4.48	3.84
Current Portion of Long-Term Debt	6.86	6.24	3.25	6.37	8.64	8.37
Current Portion of Leases	1.35	1.71	1.88	1.98	1.61	1.82
Current Unearned Revenue	6.24	7.74	5.38	25.93	26.11	30.89
Other Current Liabilities	28.88	18.18	15.08	13.59	18.54	4.99
Total Current Liabilities	98.42	93.88	82.69	95.89	97.32	86.35
Long-Term Debt	32.13	35.55	39.87	27.04	25.88	33.39
Long-Term Leases	1.44	1.13	1.36	1.83	2.01	1.92
Long-Term Unearned Revenue	10.78	12.64	17.17	22.14	44.9	68.63
Other Long-Term Liabilities	0.05	0.05	0.19	0.19	0.19	0.19
Total Liabilities	142.82	143.25	141.29	147.08	170.3	190.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	10.8	10.8	10.93	11.01	11.01	11.01
Additional Paid-In Capital	45.91	45.91	59.86	71.28	71.28	71.28
Retained Earnings	239.78	233.83	168.38	142.22	156.51	121.29
Treasury Stock	-45.74	-38.72	-30.83	-31.09	-15.87	-25.68
Comprehensive Income & Other	0.03	0.02	0.02	0.02	0.02	0.02
Total Common Equity	250.78	251.83	208.36	193.44	222.96	177.92
Shareholders' Equity	250.78	251.83	208.36	193.44	222.96	177.92
Total Liabilities & Equity	393.6	395.08	349.64	340.52	393.26	368.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	45.84	49.42	51.08	43.67	42.63	49.33
Net Cash (Debt)	123.04	117.81	103.45	118.89	139.79	152.55
Net Cash Growth	60.46%	13.88%	-12.99%	-14.95%	-8.36%	9.86%
Net Cash Per Share	6.81	6.75	5.89	6.64	7.74	8.44
Filing Date Shares Outstanding	17.34	17.36	17.57	17.64	18.11	18.01
Total Common Shares Outstanding	17.34	17.36	17.57	17.64	18.11	18.01
Working Capital	182.53	189.54	167.55	156.71	177.86	208.89
Book Value Per Share	14.47	14.51	11.86	10.97	12.31	9.88
Tangible Book Value	246.76	250.48	207.36	192.2	221.77	176.79
Tangible Book Value Per Share	14.23	14.43	11.80	10.90	12.25	9.82
Land	-	37.86	36.04	29.04	29.04	22.59
Machinery	-	64.18	60.68	43.28	27.87	24.32

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error